Odyssey Therapeutics, Inc. (ODTX) — Institutional Holders, Q2 2026

59 institutional investment managers reported a ODTX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $652.9M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

ODTX 13F holders ranked 1–59 of 59

Institutional investors reporting a position in Odyssey Therapeutics, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
FMR#1 · 5,179,262 sh$96.9M—
SR ONE CAPITAL MANAGEMENT#2 · 3,794,883 sh$71.0M—
TPG GP A#3 · 3,690,146 sh$69.0M—
Lightspeed Management Company, L.L.C.#4 · 3,608,443 sh$67.5M—
ORBIMED ADVISORS#5 · 3,001,198 sh$56.2M—
Sanofi#6 · 1,991,918 sh$37.3M—
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)#7 · 1,046,139 sh$19.6M—
Sands Capital Ventures#8 · 875,000 sh$16.4M—
Hillhouse Capital Advisors, Ltd.#9 · 831,656 sh$15.6M—
General Catalyst Group Management#10 · 810,272 sh$15.2M—
Affinity Asset Advisors#11 · 766,346 sh$14.3M—
ADAGE CAPITAL PARTNERS GP, L.L.C.#12 · 725,000 sh$13.6M—
VANGUARD CAPITAL MANAGEMENT#13 · 720,440 sh$13.5M—
Foresite Capital Management V#14 · 713,105 sh$13.3M—
Vivo Capital#15 · 575,000 sh$10.8M—
EcoR1 Capital#16 · 555,555 sh$10.4M—
Logos Global Management#17 · 521,736 sh$9.8M—
MARSHALL WACE, LLP#18 · 492,697 sh$9.2M—
PRICE T ROWE ASSOCIATES#19 · 471,987 sh$8.8M—
Catalio Capital Management#20 · 457,839 sh$8.6M—
Redmile Group#21 · 425,000 sh$8.0M—
BALYASNY ASSET MANAGEMENT L.P.#22 · 393,862 sh$7.4M—
Woodline Partners#23 · 345,746 sh$6.5M—
FRANKLIN RESOURCES#24 · 275,022 sh$5.1M—
Boxer Capital Management#25 · 275,000 sh$5.1M—
BlackRock#26 · 240,679 sh$4.5M—
CITADEL ADVISORS#27 · 222,450 sh$4.2M—
Siren, L.L.C.#28 · 200,000 sh$3.7M—
GEODE CAPITAL MANAGEMENT#29 · 189,488 sh$3.5M—
Cormorant Asset Management#30 · 175,000 sh$3.3M—
abrdn plc#31 · 165,000 sh$3.1M—
TWO SIGMA INVESTMENTS#32 · 156,602 sh$2.9M—
GOLDMAN SACHS GROUP#33 · 132,801 sh$2.5M—
CHARLES SCHWAB INVESTMENT MANAGEMENT#34 · 101,531 sh$1.9M—
VANGUARD FIDUCIARY#35 · 100,905 sh$1.9M—
STATE STREET#36 · 78,950 sh$1.5M—
Hudson Bay Capital Management#37 · 72,918 sh$1.4M—
UBS Group AG#38 · 68,758 sh$1.3M—
Ensign Peak Advisors#39 · 64,621 sh$1.2M—
SEVEN GRAND MANAGERS#40 · 50,000 sh$935.5K—
Eversept Partners#41 · 49,658 sh$929.1K—
TUDOR INVESTMENT ET AL#42 · 44,171 sh$826.4K—
NORTHERN#43 · 34,588 sh$647.1K—
MANUFACTURERS LIFE INSURANCE COMPANY, THE#44 · 32,125 sh$601.1K—
TD ASSET MANAGEMENT#45 · 29,134 sh$545.1K—
JPMORGAN CHASE#46 · 27,787 sh$524.9K—
Ghisallo Capital Management#47 · 25,000 sh$467.8K—
Burkehill Global Management#48 · 20,000 sh$374.2K—
D. E. Shaw#49 · 19,848 sh$371.4K—
XTX Topco Ltd#50 · 16,552 sh$309.7K—
VANGUARD PORTFOLIO MANAGEMENT#51 · 13,685 sh$256.0K—
Vanguard Global Advisers#52 · 7,948 sh$148.7K—
Omega Fund Management#53 · 2,893 sh$54.1K—
Legal & General Group Plc#54 · 2,000 sh$37.3K—
WELLS FARGO & COMPANY#55 · 1,795 sh$33.6K—
MORGAN STANLEY#56 · 1,772 sh$33.2K—
BARCLAYS PLC#57 · 1,459 sh$27.3K—
CITIGROUP#58 · 511 sh$9.6K—
Tower Research Capital (TRC)#59 · 193 sh$3.6K—

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for the prior quarter without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.